Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
2018 · The Lancet Neurology · 177 citations
https://doi.org/10.1016/s1474-4422(18)30319-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
212
Citations
3
h-index
2
i10-index
C Richard is an academic researcher from University of Groningen. The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Vestibular and auditory disorders & Cystic Fibrosis Research Advances. The author has an h-index of 3, co-authored 6 publications.
https://doi.org/10.1016/s1474-4422(18)30319-3
https://doi.org/10.1017/s1041610220002288
Click to start Chat